This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.
Price Action
With a market capitalization of 310.48 Crores on Tuesday, the shares of Trident Lifeline Ltd fell by 1.82 percent marking a day’s low of Rs 270 compared to its previous closing price of Rs 410.70. The stock has delivered around 42 percent in the past year and has outperformed the Nifty Index.
What Happened
The stocks of Trident Lifeline rose after the company’s board to acquire 51 percent of Trident Mediquip. This acquisition would allow the company to aid in improving its presence. The time period for this acquisition is approximately one month. In FY24, the Trident Mediquip has Rs. 20.58 crore as turnover and it is in the business of pharmaceutical and chemical business.
About the Company
Trident Lifeline Limited was established in 2014. It is a pharmaceutical company focused on providing high-quality and affordable medications. Their business model includes manufacturing finished dosages under its own brands, utilizing a loan license model, and engaging in contract manufacturing.
They operate primarily in emerging markets across Africa and Asia, with a strong global supply chain and a commitment to improving access to essential pharmaceuticals. Trident Lifeline aims to expand its product portfolio over the period.
Financials & Ratios
Its Revenue from operations increased by 57.42 percent year on year from Rs. 18.58 Crore in H1FY24 to Rs. 29.25 Crore in Q2FY25, accompanied by profits of Rs. 3.11 Crore to Rs. 4.41 Crore.
In terms of Return ratios, it has reported a return on equity (ROE) of 12.06 percent and a return on capital employed (ROCE) of 14.99 percent. It has a net profit margin of 13.31 percent as of FY24.
Shareholding Pattern
As of September 2024, the shareholding pattern with the promoter’s stake holding a share of 62.99 percent in Trident Lifeline, Foreign Institutional investors (FII) holding around 6.09 percent, and public holdings standing at 30.92 percent.
Written by Santhosh S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
